QUICKLINKS AND VIEW OPITONS
Niacin use associated with a 34% reduction in cardiovascular events
Wednesday, March 09, 2016 5:17 pm Email this article
Niacin use was associated with a 34% reduction in cardiovascular events which was defined as cardiac death, nonfatal myocardial infarction, hospitalization for acute coronary syndrome, stroke, or revascularization procedure according to a review of 11 trials including 9,956 subjects done by researchers at Tufts Medical Center in Boston, Massachusetts, USA.
“The consensus perspective derived from available clinical data supports that niacin reduces [cardiovascular disease] events,” the paper concluded.
Unfortunately, only one study gave niacin alone. The other 10 of the 11 studies gave niacin plus a statin or other cholesterol-lowering drug.
Other articles about niacin
Other articles about niacin are posted here.
Lavigne PM, and Karas RH. The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression. J Am Coll Cardiol, 2013 Jan 29; 61(4): 440-446.
Author’s Contact Info
Richard H. Karas, MD, PhD
Molecular Cardiology Research Center
Tufts Medical Center
800 Washington Street, #80
Boston, Massachusetts 02111
The paper is posted here.
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.